Search Results

240 results for NOVL

The Rise of Custom AI Chips Is Breaking Nvidia’s Grip

Custom AI chips are replacing Nvidia GPUs for inference. Here’s how Big Tech is shifting — and which companies benefit most.

War, Watts, and the AI Buildout That Won’t Stop

On this week’s Being Exponential, Luke connects the dots between the Iran blockade, orbital compute, prediction markets, and the biggest headwind facing AI stocks right…

The Market Has Already Changed … but Most Investors Haven’t

When Amazon went public, those who understood what was coming and moved early built a fortune. Everyone who waited for confirmation might still have made…

Anthropic’s Claude Mythos Leak Is Bigger Than You Think

Anthropic’s Claude Mythos leak reveals a major AI breakthrough – boosting infrastructure stocks while putting SaaS business models at risk.

5 Option Trades on Hot Takeover Rumors

It seems we hear rumors every day about which company is next in line to be acquired. Find out how to play the hottest ones.

14 Stocks to Buy Near New 52-Week Highs

Some simple trading strategies involve buying oversold stocks with great numbers — but another great investment strategy for your retirement money is to buy stocks…

Novell — Stealthy Market Leader

NOVL is a high-quality, cash-flow-positive software company that has been almost forgotten in this two-month market rally.

Stock Up on Kroger Call Options

A bullish options trade ahead of Kroger Co. (NYSE: KR) earnings could pay off.

TIVO Options – Speculative TIVO Options Could Record Big Profits

TiVo Inc. (NASDAQ: TIVO) was cut in half following news that its patent victory would be heard in appeals court. But a reversal trade could…

Watching the End of the Week

A strong end-of-week rally in the face of more bad news could get the bulls in a holiday-party mood.

Eli Lilly vs. Novo Nordisk: A Tale of Two Stocks

In today’s Market 360, I want to walk you through this evolving rivalry – and show you why identifying true market leaders is critical in…

Sweet 16 Option Trades

Top traders offer up their game-winning ideas for OptionsZone’s Annual March Madness Contest.

Kindle Delivers for Amazon

The electronic reader keeps its grip on the digital book market, becoming the company’s all-time bestseller.

Harry Potter and the Cursed Child: 9 Things to Know

‘Harry Potter and the Cursed Child’ is the name of the new JK Rowling book and it will be released on July 31. Here are…

3 Best Stocks to Buy for Soaring Oil Prices

If you’re looking for stocks to buy and believe in rising oil prices, it doesn’t get much better than these three names.

How to Decide If Fastly Is a $70 or $90 Stock

Despite the TikTok threat seemingly over for Fastly, FSLY stock doesn’t seem like it wants to take the next leg up on its way to…

Can Barnes & Noble’s Nook Grow Its Market Share?

The e-reader wars rage on, as Barnes & Noble’s Nook battles hard for market share.

3 Underappreciated Biotech Stocks to Buy Now: May 2024

Vertex Pharmaceuticals (VRTX), United Therapeutics (UTHR), and Novo Nordisk (NVO) are the top 3 biotech stocks to buy in May 2024.

3 Biotech Stocks Set to Double by 2028

These are three of the top biotech stocks set to double by 2028. Add them to your portfolio to maximize your potential gains.

Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making

These three companies represent the world of biotech stocks and offer a unique blend of high risk and potentially high reward.

Will ‘Casual Vacany’ Bump ‘Fifty Shades of Grey’?

The ‘Harry Potter’ author is moving into adult themes in her new book. With 1 million pre-orders already, she already has another hit.

Sorrento Therapeutics Remains a Buy Between $6 and $6.50

Sorrento Therapeutics has seen SRNE stock close between $5.76 and $8.20 in the past month. Here’s why it’s time for investors to be careful. 

As the Purchase Orders Build, Workhorse Group Will Ultimately Succeed

Workhorse Group got another purchase order for its C-1000. Eventually, this will translate into real growth for WKHS stock. 

Is It Time to Buy Sorrento Stock After Its Month-Long Swoon?

Sorrento stock has lost 50% over the past month. Investors have grown impatient with the company’s Covid-19 efforts. Time to buy or sell?

1 – 10 of 240 results